Loading organizations...
Loading organizations...
Biotechnology company developing therapies for immunological disorders.
Apogee Therapeutics has raised $149.0M across 1 funding round.
Apogee Therapeutics has raised $149.0M in total across 1 funding round.
Apogee Therapeutics has raised $149.0M in total across 1 funding round.
Apogee Therapeutics's investors include Rebecca Luse, RTW Investments.
Apogee Therapeutics has raised $149.0M across 1 funding round. Most recently, it raised $149.0M Series B in December 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 12, 2022 | $149.0M Series B | Rebecca Luse, RTW Investments |